secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seres Therapeutics, Inc. (MCRB)
CIK:        0001609809
Form:       8-K
Filed at:   2025-04-22T23:59:59+00:00
Accession:  0001193125-25-089189
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seres Therapeutics effects 1-for-20 reverse stock split, effective April 21, 2025
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-20 ratio, effective 5:00 PM ET on April 21, 2025.
- Common stock begins split-adjusted trading on Nasdaq on April 22, 2025 under symbol MCRB.
- No fractional shares will be issued; holders receive cash in lieu of fractional shares.
- Authorized shares and par value per share remain unchanged.
- Stockholders approved split range of 1:5 to 1:50; Board fixed final ratio at 1:20.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609809/000119312525089189/0001193125-25-089189-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609809/000119312525089189/d97309d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-089189

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer